In-hospital stay of patient with acute coronary syndrome with or without diabetes mellitus

Minerva Cardioangiologica

Volumn 57, Issue 2, 2009, Pages 159-164

  Novo, G ^a   Scordato, F ^a   Cerruto, G ^a   Vitale, G ^a   Ciaramitaro, G ^a   Coppola, G ^a   Farinella, M ^a   Rotolo, A ^a   Indovina, G ^a   Assennato, P ^a   Novo, S ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

Acute coronary syndrome; Coronary disease; Diabetes mellitus, type 2

Indexed keywords

ACUTE CORONARY SYNDROME; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HOSPITALIZATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INTENSIVE CARE UNIT; ITALY; LENGTH OF STAY; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS;

EID: 67649610917     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Haffner SM, Lehto S. Mortality from coronary heart disease in subjects with type 2 diabetes and in non diabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-234 (Pubitemid 28350165)
2. Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for the Ischemic Syndrome) Registry. Circulation 2000;102:1014-1019 (Pubitemid 30656008)
3. Nesto RW. Correlation between cardiovascular disease and diabetes mellitus: current concepts. Am J Med 2004;116:11S-22S. (Pubitemid 38333037)
4. Haffner SM. Coronary heart disease in patients with diabetes. Circulation 2000;342:1040-1042 (Pubitemid 30180652)
5. Solomon CG. Reducing cardiovascular risk in type 2 diabetes. N Engl Med 2003;348:457-459 (Pubitemid 36159365)
6. Mehran R, Dangas GD, Kobayashi Y, Lansky AJ, Mintz GS, Aymong ED et al. Short and long term results after multivessel stenting in diabetic patients. JACC Cardiovasc Imaging 2004;43:1348-1354 (Pubitemid 38496336)
7. Darren K, McGuire L, Newby K, Bhapkar MV, Moliterno DJ, Hochman JS et al. Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes. Am Heart J 2004;147:246-252 (Pubitemid 38176824)
8. Gaede P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patient with type 2 diabetes. N Engl J Med 2003;348:383-393 (Pubitemid 36159355)
9. Pastermark RC. Report of the Adult Treatment Panel III: The 2001 National Cholesterol Education Program Guideline on the Detection, Evaluation and Treatment of Elevated Cholesterol in Adults. Cardiol Clin 2003;3:393-398
10. American Diabetes Association: Standards of medical care for patient with diabetes mellitus. Diabetes Care 2003;26(Suppl 1):S33-S50. (Pubitemid 36928957)
11. Mazzone T. Strategies in ongoing clinical trials to reduce cardiovascular disease in patients with diabetes mellitus and insulin resistance. Am J Cardiol 2004;93(Suppl. C):27C-31C. (Pubitemid 38721318)
12. Jonsson B, Cook JR, Pedersen TR. The cost-effectiveness of lipid-lowering with diabetes: result from the 4S trial. Diabetologia 1999;42:1293-1301 (Pubitemid 29500965)
13. Mihaylova B, Briggs A, Armitage J, Parish S, Gray A, Collins R; Heart Protection Study Collaborative Group. Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomized trial in 20 536 individuals. Lancet 2005;365:1779-1785 (Pubitemid 40744658)
14. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002;359:2140-2144 (Pubitemid 34694020)
15. Carrala F, Aguilara M, Olveirab G, Mangasc A, Domènecha I, Torrefa I: Increased hospital expenditures in diabetic patients hospitalized for cardiovascular diseases. J Diabetes Complications 2003;17:331-336 (Pubitemid 37315942)
16. Williams R, Van Gaal L, Lucioni C. Assessing the impact of complications on the costs of Type II diabetes. Diabetologia 2002;45:S13-S7. (Pubitemid 34762209)
17. Köster I, von Ferber L, Ihle P, Schubert I, Hauner H. The cost burden of diabetes mellitus: the evidence from Germany - the CoDiM Study. Diabetologia 2006;49:1498-1504 (Pubitemid 43848085)
18. Jorik R, Timmera JP, Ottervangera KT, Hoorntjea JCA, de Boera MJ, Harry Suryapranataa et al., on behalf of the Zwolle myocardial infarction study group: Long-term, cause-specific mortality after myocardial infarction in diabetes. Eur Heart J 2004;25:926-931
19. Fonarow GC. Managing the patient with diabetes mellitus and heart failure: Issues and Considerations. Am J Med 2004;116(5A):76S-88S. (Pubitemid 38333043)
20. Klein L, Gheorghiade M. Management of the patient with diabetes mellitus and myocardial infarction: clinical trials update. Am J Med 2004;116(Suppl 5A):47S-63S. (Pubitemid 38333041)
21. Wong VW, Ross DL, Park K, Boyages SC, Cheunga NW. Hyperglycaemia: still an important predictor of adverse outcomes following AMI in the reperfusion era. Diabetes Research Clin Pract 2004;64:85-91. (Pubitemid 38456686)
22. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T et al. Hyperglycemia and acute coronary syndrome: A scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2008;117:1610-1619
23. Malberg K for the DIGAMI Study Group. Prospective randomized study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 1997;314:1512-1515
24. Almbrand B, Johannesson M, Sjo B, Malmberg K, Rydèn L. Cost-effectiveness of intensive insulin treatment after acute myocardial infarction in patients with diabetes mellitus. Results from the DIGAMI Study. Eur Heart J 2000;21:733-739 (Pubitemid 30201365)
25. Malmberg K, Rydèn L, Wedel H, Birkeland K, Bootsma A, Dickstein K et al. for the DIGAMI 2 investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005;26:650-661
26. Cheung NW, Wong VW, McLean M. The hyperglycemia: intensive insulin infusion in infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 2006;29:765-70. (Pubitemid 44115291)
27. Mehta SR, Yusuf S, Diaz R, Zhu J, Pais P, Xavier D et al. CREATE-ECLA Trial Group. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005;293:437-446
28. Giorda C, Maggini M, Spila Alegiani S, Turco S, Raschetti R for the DAI Study. Secondary prevention of coronary artery disease in high risk diabetic patients. Nutr Metab Cardiovasc Dis 2003;13:238-243